AUGUSTA (AP) — Maine is among 20 states suing six generic drug-makers with a claim that the companies artificially inflated prices for an antibiotic and an oral diabetes medication.
Attorney General Janet Mills says the federal lawsuit accuses the companies of manipulating prices and reducing competition for a pair of drugs that many state residents buy as lower-cost generics.
She accuses the drugmakers of putting profits over people who need affordable medicine.
The lawsuit was filed Thursday in U.S. District Court in Connecticut. The companies targeted in the lawsuit are Heritage Pharmaceuticals,
Aurobindo Pharma USA, Citron Pharma, Mayne Pharma (USA), Mylan Pharmaceuticals and Teva Pharmaceuticals USA.
The lawsuit stems from a Connecticut state investigation of the reasons behind prices increases of certain generic pharmaceuticals. That investigation is still ongoing.
Comments are not available on this story. Read more about why we allow commenting on some stories and not on others.
We believe it's important to offer commenting on certain stories as a benefit to our readers. At its best, our comments sections can be a productive platform for readers to engage with our journalism, offer thoughts on coverage and issues, and drive conversation in a respectful, solutions-based way. It's a form of open discourse that can be useful to our community, public officials, journalists and others.
We do not enable comments on everything — exceptions include most crime stories, and coverage involving personal tragedy or sensitive issues that invite personal attacks instead of thoughtful discussion.
You can read more here about our commenting policy and terms of use. More information is also found on our FAQs.
Show less